Abstract Objectives Extracorporeal Life Support (ECLS) may provide pulmonary and
circulatory support for patients with acute heart failure refractory to conventional medical …

OBJECTIVES Although post-cardiotomy extracorporeal life support (PC-ECLS) is a
potentially life-saving resource for patients with cardiopulmonary failure after cardiac …

Background Extracorporeal life support (ECLS) therapy is increasingly used for cardiac and
respiratory support postcardiotomy, refractory cardiogenic shock and cardiopulmonary …

Background Weaning failure from cardiopulmonary bypass, postoperative low cardiac
output (LCO), and cardiopulmonary resuscitation (CPR) are common scenarios preceding …

Objectives: The use of post-cardiotomy extracorporeal life support (PC-ECLS) has increased
worldwide over the past years but a concurrent decrease in survival to hospital discharge …

Aim To describe our experience in the clinical application of extracorporeal life support
(ECLS) and analyze whether ECLS leads to acceptable clinical outcomes in patients with …

Objective: Risk factors for adverse outcome after extracorporeal life support (ECLS) are yet
to be defined. For this purpose, we reviewed our institutional data from more than a decade …

Background Extracorporeal life support (ECLS) is widely used in refractory cardiac or
pulmonary failure. Because complications of general thoracic surgery frequently involve the …

Post-cardiotomy extracorporeal life support (PC-ECLS) in adult patients has been used only
rarely but recent data have shown a remarkable increase in its use, almost certainly due to …

OBJECTIVES Venoarterial extracorporeal life support (ECLS) has emerged as a potentially
life-saving treatment option in therapy-refractory cardiocirculatory failure, but longer-term …